Oxygen sensing by HIF hydroxylases
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under well-oxygenated conditions HIFα becomes hydroxylated at one (or both) of two highly conserved prolyl residues located near the NTAD by members of the prolyl hydroxylase domain (PHD) family (also called EgIN family or HPH family) (for reviews see Kaelin, 2005; Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“When oxygen is available, FIH1 hydroxylates a conserved asparaginyl residue within the HIF1α and HIF2α CTADs, leading to a steric clash that prevents the recruitment of the coactivators p300 and CBP (for reviews see Kaelin, 2005; Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“Ascorbate is required for full catalytic activity and likely functions to reduce the catalytic iron in the event of uncoupled turnover, in which failure to oxidize the HIFα substrate leaves the iron center in an oxidized and inactive form (Schofield and Ratcliffe, 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Schofield and Ratcliffe, 2004
In the citing paper
“This hydroxylation is mediated by prolyl-4-hydroxylases (PHDs), a set of oxygen-, iron-, and ascorbatedependent enzymes belonging to the 2-oxoglutarate-dependent oxygenase superfamily (Schofield & Ratcliffe, 2004).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Schofield & Ratcliffe, 2004
In the citing paper
“From a mechanistic standpoint, HIF activation drives tumor progression by coordinating transcriptional programs that promote glycolytic metabolism, angiogenic factor production, cell survival, proliferation, immune evasion, and maintenance of cancer stem like properties [20,250,251].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [250]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“For example, defects in the genes that encode the succinate dehydrogenase subunits B, C and”
Background
Cited by
Items 901–1,000 of 1,005
Iron and colorectal cancer: evidence from in vitro and animal studies
Padmanabhan, H., Brookes, M., & Iqbal, T. H. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu015 · Cited by 35
Transcriptome Remodeling in Hypoxic Inflammation
Safronova, O. S., & Morita, I. (2010) · Journal of Dental Research · doi:10.1177/0022034510366813 · Cited by 40
“HIF itself has been shown to mediate NF-κB activation through two independent pathways (Scortegagna et al., 2008).”
BackgroundBiju, M. P., Akai, Y., Shrimanker, N., & Haase, V. H. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00233.2005 · Cited by 35
The hypoxic response and aging
Kaeberlein, M. R., & Kapahi, P. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9126 · Cited by 40
Kong, T., Scully, M., Shelley, C. S., & Colgan, S. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1934 · Cited by 34
“The molecular mechanisms that mediate this induction involve the heterodimeric transcription factor hypoxia-inducible factor-1 (HIF-1)(3) (17, 18).”
BackgroundOxygen-Generating Biomaterials for Translational Bone Regenerative Engineering
Hosseini, F. S., Abedini, A. A., Chen, F., Whitfield, T., Ude, C. C., & Laurencin, C. T. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20715 · Cited by 39
Gestational hypoxia and epigenetic programming of brain development disorders
Ma, Q., Xiong, F., & Zhang, L. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.010 · Cited by 35
“However, under hypoxic conditions, the HIF-1α degradation process is suppressed because of inactivation of the HIF hydroxylases complex [45].”
BackgroundIzuishi, K., Yamamoto, Y., Sano, T., Takebayashi, R., Nishiyama, Y., Mori, H., Masaki, T., Morishita, A., & Suzuki, Y. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1727-z · Cited by 34
Zhang, Y., Farrants, H., & Li, X. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201400111 · Cited by 34
A genetically encoded biosensor for visualizing hypoxia responsesin vivo
Misra, T., Baccino-Calace, M., Meyenhofer, F., Rodríguez-Crespo, D., Akarsu, H., Armenta-Calderón, R., Gorr, T. A., Frei, C., Cantera, R., Egger, B., et al. (2016) · Biology Open · doi:10.1242/bio.018226 · Cited by 40
“…as a regulator of responses to changing O2 levels, it is now known to control a wide variety of functions, including hormonal regulation, energy metabolism, cell migration, growth, apoptosis, angiogenic signalling and matrix and barrier functions (reviewed in Schofield and Ratcliffe, 2004).”
Holt‐Martyn, J. P., Chowdhury, R., Tumber, A., Yeh, T., Abboud, M. I., Lippl, K., Lohans, C. T., Langley, G. W., Figg, W. D., McDonough, M. A., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900557 · Cited by 33
Self-citationBrewitz, L., Tumber, A., & Schofield, C. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012202 · Cited by 34
“ation of the hypoxia-inducible transcription factors (HIFs) that work to ameliorate the effects of limited oxygen availability (hypoxia) (23, 24).”
BackgroundSelf-citationLopes, L. G. D. F., Júnior, F. S. G., Holanda, A. K. M., de Carvalho, I. M. M., Longhinotti, E., Paulo, T. D. F., Abreu, D. S., Bernhardt, P. V., Gilles‐Gonzalez, M., Diógenes, I. C. N., et al. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214096 · Cited by 40
Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease
Jayakumar, D., Narasimhan, K. K. S., & Kalaiselvi, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126882 · Cited by 35
Minchenko, O. H., Opentanova, I. L., Ogura, T., Minchenko, D. O., Комісаренко, С. В., Caro, J., & Esumi, H. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3402 · Cited by 42
“This reaction is mediated by specific irondependent prolyl hydroxylases that utilize oxoglutarate as a co-substrate (Epstein et al., 2001; Lando et al., 2002; Mole et al., 2003; Schofield & Ratcliffe, 2004).”
BackgroundJung, H. J., Kim, J. H., Shim, J. S., & Kwon, H. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135632 · Cited by 38
A common pathway for genetic events leading to pheochromocytoma
Maxwell, P. H. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.012 · Cited by 40
HOMAN, A., Guan, H., Hardy, D. B., Gratton, R. J., & Yang, K. (2005) · Placenta · doi:10.1016/j.placenta.2005.09.006 · Cited by 41
Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion
Yeoh, K. K., Chan, M. C., Thalhammer, A., Demetriades, M., Chowdhury, R., Tian, Y., Stolze, I. P., McNeill, L. A., Lee, M. K., Woon, E. C. Y., et al. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob26648b · Cited by 34
Self-citationUnderstanding hypoxia signalling in cells – a new therapeutic opportunity?
Ratcliffe, P. J. (2006) · Clinical Medicine · doi:10.7861/clinmedicine.6-6-573 · Cited by 37
Self-citationThomas, A., Belaidi, E., Aron-Wisnewsky, J., van der Zon, G. C., Levy, P., Clement, K., Pepin, J.-L., Godin-Ribuot, D., & Guigas, B. (2016) · Scientific Reports · doi:10.1038/srep24618 · Cited by 33
Nalbantoğlu, S., & Karadağ, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114031 · Cited by 39
Hill, R. M., Rocha, S., & Parsons, J. L. (2022) · Cancers · doi:10.3390/cancers14174130 · Cited by 41
“The hydroxylation of HIF-1α at prolines 402 and 564 increases the affinity of the protein for the tumour suppressor protein von Hippel-Lindau (VHL) [37,38].”
BackgroundInfluentialShaikat, A. H., Azad, S. M. A. K., Tamim, M. A. R., Ullah, M. S., Amin, M. N., Sabbir, M. K., Tarun, M. T. I., Mostaq, M. S., Sabrin, S., Mahmud, M. Z., et al. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.07.003 · Cited by 44
“39 In the absence of asparaginyl hydroxylation, HIF-1 α can interact with the coactivators p300 and CBP, allowing HIF-1 target genes such as VEGF to be transcriptionally activated, which in turn attracts endothelial cells to hypoxic and avascular regions and promotes their growth.”
Jamadarkhana, P., Chaudhary, A., Chhipa, L., Dubey, A., Mohanan, A., Gupta, R., & Deshpande, S. (2012) · American Journal of Nephrology · doi:10.1159/000341870 · Cited by 33
5‐Hydroxymethylcytosin, die sechste Base des Genoms
Münzel, M., Globisch, D., & Carell, T. (2011) · Angewandte Chemie · doi:10.1002/ange.201101547 · Cited by 34
Scanlon, S. E., Hegan, D. C., Sulkowski, P. L., & Glazer, P. M. (2017) · Oncotarget · doi:10.18632/oncotarget.23470 · Cited by 35
Need (more than) two to Tango: Multiple tools to adapt to changes in oxygen availability
Fratantonio, D., Cimino, F., Speciale, A., & Virgili, F. (2018) · BioFactors · doi:10.1002/biof.1419 · Cited by 38
“However, the HIF system therefore seems to be set differently in different cells, in order to allow a tissue-specific control of oxygen homeostasis [55].”
BackgroundChen, Y., Fang, L., Zhou, W., Chang, J., Zhang, X., He, C., Chen, C., Yan, R., Yan, Y., Lu, Y., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00989-z · Cited by 33
“Under hypoxic conditions, HIF-1αdependent ubiquitin–proteasome degradation pathway is blocked, and HIF-1α is able to translocate into the nucleus to form HIF-1 with the β subunit, thereby initiating or enhancing the transcription of effector genes [6].”
BackgroundAkiyama, M., Mizokami, T., Miyamoto, S., & Ikeda, Y. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108949 · Cited by 36
Wang, X., Tang, Y., Liang, J., Zhao, Y., Yang, L., & Qi, Z. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.139838 · Cited by 33
Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins
Arambula, J. F., Preihs, C., Borthwick, D. M., Magda, D. J., & Sessler, J. L. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011795255894 · Cited by 37
PHD2 Is a Regulator for Glycolytic Reprogramming in Macrophages
Güntsch, A., Beneke, A., Swain, L., Farhat, K., Nagarajan, S., Wielockx, B., Raithatha, K., Dudek, J., Rehling, P., Zieseniß, A., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00236-16 · Cited by 33
“The protein stability of HIFα is regulated by the three prolyl-453 hydroxylase domain (PHD) enzymes PHD1, 2 and 3, which hydroxylate HIFα in an oxygen54 dependent manner (for review (4,5)).”
BackgroundThe inhibition of factor inhibiting hypoxia-inducible factor (FIH) by β-oxocarboxylic acids
Banerji, B., Conejo‐García, A., McNeill, L. A., McDonough, M. A., Buck, M. R., Hewitson, K. S., Oldham, N. J., & Schofield, C. J. (2005) · Chemical Communications · doi:10.1039/b510707e · Cited by 37
Self-citationARDent about acetylation and deacetylation in hypoxia signalling
Bilton, R. L., Trottier, E., Pouysségur, J., & Brahimi-Horn, M. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.10.002 · Cited by 34
Modulation of vascular gene expression by hypoxia
Ruas, J. L., Lendahl, U., & Poellinger, L. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282efe49d · Cited by 35
Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer
Vissers, M. C. M., Kuiper, C., & Dachs, G. U. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140118 · Cited by 32
Henri, J., Rispal, D., Bayart, É., TILBEURGH, H. V., Séraphin, B., & Graille, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.106864 · Cited by 38
Li, H., Ren, Y., Guo, S., Cheng, L., Wang, D., Yang, J., Chang, Z., & Zhao, X. (2008) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.510 · Cited by 33
“…vascular endothelial growth factor (VEGF), nitric oxide synthase (NOS), heme oxygenase-1 (HO-1) and others that are involved in the regulation of hypoxic adaptive responses such as erythropoiesis, angiogenesis (the formation of blood vessels) and vascular tone (Schofield and Ratcliffe, 2004).”
BackgroundNoguchi‐Sasaki, M., Sasaki, Y., Shimonaka, Y., Mori, K., & Fujimoto-Ouchi, K. (2016) · BMC Cancer · doi:10.1186/s12885-016-2305-2 · Cited by 36
“Hypoxic and anemic conditions are known to increase the synthesis of the hormone EPO which leads to the production of erythrocytes [24]; therefore, we measured EPO levels in this mouse model.”
Abboud, M. I., McAllister, T. E., Leung, I. K. H., Chowdhury, R., Jorgensen, C., Domene, C., Mecinović, J., Lippl, K., Hancock, R. L., Hopkinson, R. J., et al. (2018) · Chemical Communications · doi:10.1039/c8cc00387d · Cited by 31
Self-citationHIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
Billin, A. N., Honeycutt, S. E., McDougal, A. V., Kerr, J. P., Chen, Z., Freudenberg, J., Rajpal, D. K., Luo, G., Kramer, H. F., Geske, R. S., et al. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0179-5 · Cited by 33
HIF hydroxylase inhibitors decrease cellular oxygen consumption depending on their selectivity
Sulser, P., Pickel, C., Günter, J., Leissing, T. M., Crean, D., Schofield, C. J., Wenger, R. H., & Scholz, C. C. (2019) · The FASEB Journal · doi:10.1096/fj.201902240r · Cited by 32
Self-citationVanderhaeghen, T., Beyaert, R., & Libert, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684085 · Cited by 34
“Hypoxia and inflammation are unequivocally linked (104).”
Hussain, K., Liu, R., Smith, R. C. G., Müller, K. T. J., Ghorbani, M., Macari, S. A., Cleary, K. L. S., Oldham, R. J., Foxall, R. B., James, S., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02294-5 · Cited by 36
“hypoxia, HIF-PH-mediated hydroxylation of HIF-α subunits and their subsequent degradation is inhibited, allowing HIF-α to accumulate, facilitating its dimerization with HIF-1β (ARNT) and subsequent target gene binding and transcription [73].”
BackgroundZhang, Z., Shi, C., & Wang, Z. (2023) · Nutrients · doi:10.3390/nu15132833 · Cited by 38
Schörg, A., Santambrogio, S., Platt, J. L., Schödel, J., Lindenmeyer, M. T., Cohen, C. D., Schrödter, K., Mole, D. R., Wenger, R. H., & Hoogewijs, D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv506 · Cited by 36
“HIF prolyl-4hydroxylation leads to the binding of the E3 ubiquitin ligase von Hippel–Lindau protein (pVHL) followed by polyubiquitination and proteasomal destruction (2,3).”
BackgroundKroeze, S. G. C., Vermaat, J. S. P., van Brussel, A. S. A., van Melick, H. H. E., Voest, E. E., Jonges, T. G. N., van Diest, P. J., Hinrichs, J. W. J., Bosch, J. L. H. R., & Jans, J. J. M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.018 · Cited by 36
Structural and mechanistic studies on the peroxisomal oxygenase phytanoyl-CoA 2-hydroxylase (PhyH)
Schofield, C. J., & McDonough, M. A. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350870 · Cited by 37
Self-citationIKK2 Inhibition Attenuates Laser-Induced Choroidal Neovascularization
Lü, H., Lu, Q., Gaddipati, S., Kasetti, R. B., Wang, W., Pasparakis, M., Kaplan, H. J., & Li, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087530 · Cited by 33
“factor for VEGF during hypoxia [16,51], and a recent study showed that transcriptional activation of the Hif1a gene by IKK2activated NF-kB precedes HIF1A protein accumulation both ex vivo and in vivo [52].”
BackgroundThe role of the PTEN gene in malignant gliomas
Alexiou, G. Α., & Voulgaris, S. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60408-4 · Cited by 32
“PI3K/AKT signalling modulates the HIF-1α pathway.”
BackgroundInfluentialMitoxantrone Inhibits HIF-1α Expression in a Topoisomerase II–Independent Pathway
Toh, Y.-M., & Li, T.-K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0235 · Cited by 32
“Under conditions of hypoxia, where hydroxylases are inactivated, the HIF-1a protein is stabilized, and it translocates into the nucleus to form an active complex with HIF-1b (10).”
BackgroundInfluentialVerma, A. M. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232895.28674.79 · Cited by 34
Cobley, J. N., & Husi, H. (2020) · Antioxidants · doi:10.3390/antiox9040315 · Cited by 34
“Such work would advance understanding of how we sense O2 [176].”
BackgroundBiochemistry of the hypoxia-inducible factor hydroxylases
Fiorini, G., & Schofield, C. J. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102428 · Cited by 35
Self-citationMolecular Biology of Renal Cortical Tumors
Klatte, T., & Pantuck, A. J. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.006 · Cited by 31
Miyata, T., & Dan, T. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.012 · Cited by 31
“We know that the HIF is a crucial molecule in the defense against hypoxia [14].”
BackgroundHypoxic Conversion of SMAD7 Function from an Inhibitor into a Promoter of Cell Invasion
Heikkinen, P. T., Nummela, M., Jokilehto, T., Grenman, R. A., Kähäri, V., & Jaakkola, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3777 · Cited by 33
“HIF activity is regulated in an oxygen-dependent manner by HIF prolyl hydroxylases (36).”
BackgroundGuarnerio, J., Coltella, N., Ala, U., Tonon, G., Pandolfi, P. P., & Bernardi, R. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.04.002 · Cited by 33
“HIF factors are heterodimeric transcription factors composed of a and b subunits: the b subunit (ARNT) is constitutively expressed, whereas the a subunit is degraded through an oxygen-dependent mechanism and is stabilized at low oxygen concentrations (Schofield and Ratcliffe, 2004).”
BackgroundVoluntary exercise slows breast tumor establishment and reduces tumor hypoxia in ApoE−/− mice
Buss, L. A., & Dachs, G. U. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00738.2017 · Cited by 36
“This stabilizes the subunit of the hypoxia-inducible factor (HIF) transcription factors, which then dimerizes with the subunit in the nucleus and stimulates the transcription of a myriad of genes, including proangiogenic genes (63).”
BackgroundExercise induces tissue hypoxia and HIF-1α redistribution in the small intestine
Wu, D., Cao, W. W., Xiang, D., Hu, Y., Luo, B., & Chen, P. (2019) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2019.05.002 · Cited by 38
“The regulation of both PHDs and factorinhibiting HIF results in the destruction of the HIFa subunit and inactivation of transcriptional activity.(27) During hypoxia, these processes are inhibited, and a transcriptionally active complex is formed.”
BackgroundPheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
Cascón, A., Remacha, L., Calsina, B., & Robledo, M. (2019) · Cancers · doi:10.3390/cancers11050683 · Cited by 35
“This prolyl hydroxylation induces the binding of HIF-1α to the von Hippel–Lindau (VHL) protein-associated complex, which is in charge of targeting HIF-1α by ubiquitination for proteosomal degradation [103,104].”
BackgroundSystemic silencing of Phd2 causes reversible immune regulatory dysfunction
Yamamoto, A., Hester, J., Macklin, P. S., Kawai, K., Uchiyama, M., Biggs, D., Bishop, T., Bull, K. R., Cheng, X., Cawthorne, E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124099 · Cited by 32
Self-citationInhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets
Perry, G. S., Das, M., & Woon, E. C. Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01694 · Cited by 34
Szymański, T., Semba, J. A., Mieloch, A. A., Cywoniuk, P., Kempa, M., & Rybka, J. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-27901-z · Cited by 31
Hiwatashi, Y., Kanno, K., Takasaki, C., Goryo, K., Sato, T., Torii, S., Sogawa, K., & Yasumoto, K. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.09.005 · Cited by 31
Xie, X., Xiao, H., Ding, F., Zhong, H., Zhu, J., Ma, N., & Mei, J. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.04.008 · Cited by 33
Renal cancer: Oxygen meets metabolism
Haase, V. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.026 · Cited by 38
“A second hypoxia switch operates in the carboxy-terminal transactivation domain of HIF-α with O2-dependent hydroxylation of asparagine residue 803 by factor inhibiting HIF (FIH) (for review see [16, 32]).”
BackgroundLomb, D. J., Desouza, L. A., Franklin, J. L., & Freeman, R. S. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053157 · Cited by 36
“The three EGLN proteins are ironand 2-oxoglutarate-dependent dioxygenases best known for their role in destabilizing hypoxia-inducible factor (HIF) (Schofield and Ratcliffe, 2004).”
BackgroundTissue metabolism and the inflammatory bowel diseases
Lanis, J. M., Kao, D. J., Alexeev, E. E., & Colgan, S. P. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1544-2 · Cited by 30
“Functional HIF exists as an α/β heterodimer, composed of both a constitutive subunit (HIF-1β) and a hypoxia-inducible ‘α’ component, stabilization of which is regulated in part by a family of oxygen- and iron-dependent prolyl hydroxylase (PHD) enzymes [11].”
BackgroundDoes Hypoxia Cause Carcinogenic Iron Accumulation in Alcoholic Liver Disease (ALD)?
da Silva, I. S., Rausch, V., Seitz, H. K., & Mueller, S. (2017) · Cancers · doi:10.3390/cancers9110145 · Cited by 31
“For instance, despite low oxygen levels, HIF is usually not expressed in tissues and its expression has a low correlation with human cancers [101,102].”
BackgroundA HIF independent oxygen-sensitive pathway for controlling cholesterol synthesis
Dickson, A. S., Pauzaite, T., Arnaiz, E., Ortmann, B. M., West, J. A., Volkmar, N., Martinelli, A. W., Li, Z., Wit, N., Vitkup, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40541-1 · Cited by 31
“…by the oxygen-dependent prolyl hydroxylase Ofd1, with subsequent degradation of the cleaved N-terminal transcriptionally active portion of Sre1 (Sre1N) 18,20,21 in a mechanism strikingly similar to the oxygen-dependent prolyl hydroxylation of Hypoxia Inducible Factors (HIFs) in metazoans 22,23 .”
Viafara-García, S. M., Khan, M. S., Haidar, Z. S., & Acevedo, J. P. (2023) · Nanomaterials · doi:10.3390/nano13233060 · Cited by 30
Acevedo, J. M., Centanin, L., Dekanty, A., & Wappner, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012390 · Cited by 34
“Whereas the HIFb subunit is constitutive, HIFa is tightly regulated by oxygen levels through various mechanisms that include protein stability, transcription coactivator recruitment and subcellular localization [2–4].”
Yu, C., Xue, J., Zhu, W. J., Yang, J., Zhang, S., & Cao, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2875-z · Cited by 31
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
Cui, X., Tinholt, M., Stavik, B., Dahm, A. E. A., Kanse, S. M., Jin, Y., Seidl, S., Sahlberg, K. K., Iversen, N., Skretting, G., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13206 · Cited by 36
Stoehr, A., Yang, Y., Patel, S., Evangelista, A. M., Aponte, A. M., Wang, G., Liu, P., Boylston, J. A., Kloner, P. H., Lin, Y., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw081 · Cited by 35
Lu, L., Xu, H., Yang, P., Xue, J., Chen, C., Sun, Q., Yang, Q., Lü, J., Shi, A., & Liu, Q. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.027 · Cited by 32
Wang, D., Wang, Q., Yan, G., Qiao, Y., Zhu, B., Liu, B., & Tang, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9079 · Cited by 28
“Stabilization of HIF1 α results in a switch from OXPHOS towards glycolysis by binding to a hypoxia response element (HRE) in the promoter and thus upregulating glycolysis-promoting genes, such as HK, glyceraldehyde-3-phosphate dehydrogenase, LDHA and pyruvate dehydrogenase kinase 1 (PDK1) (22).”
Liu, W., Liu, X., Wu, C., & Jiang, L. (2018) · Fish Physiology and Biochemistry · doi:10.1007/s10695-018-0525-x · Cited by 33
Erber, L. N., Luo, A., & Chen, Y. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001535 · Cited by 31
Ma, X., Dong, Z., Liu, J., Ma, L., Sun, X., Gao, R., Pan, L., Zhang, J., Dilan, A., An, J., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07267-y · Cited by 37
Fakhri, S., Moradi, S. Z., Faraji, F., Kooshki, L., Webber, K. J., & Bishayee, A. (2023) · Cancer Metastasis Review · doi:10.1007/s10555-023-10136-9 · Cited by 25
Reitzner, S. M., Emanuelsson, E. B., Arif, M., Kaczkowski, B., Kwon, A. T.-J., Mardinoğlu, A., Arner, E., Chapman, M., & Sundberg, C. J. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101857 · Cited by 44
Trichonas, G., Lee, T. J., Hoppe, G., Au, J. D., & Sears, J. E. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12171 · Cited by 31
Minchenko, О. H., Ogura, T., Opentanova, I. L., Minchenko, D. O., & Esumi, H. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-8009-6 · Cited by 41
“This data clearly demonstrated that hypoxic induction of PFKFB4 isoforms is mediated by HIF-1α because dimethyloxalylglycine, a specific inhibitor of prolylhydroxylase enzymes HIF-1α, protects HIF-1α from degradation and significantly increase the levels of this protein, mimicking hypoxic conditions [14, 20, 31].”
BackgroundIron, oxygen, and the pulmonary circulation
Frise, M. C., & Robbins, P. A. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00179.2015 · Cited by 34
“The alternative fates of HIF according to iron and oxygen availability, and examples of HIF-regulated gene products that influence the pulmonary vasculature (74, 75).”
BackgroundEGF regulation of proximal tubule cell proliferation and VEGF-A secretion
Zepeda‐Orozco, D., Wen, H., Hamilton, B. A., Raikwar, N. S., & Thomas, C. P. (2017) · Physiological Reports · doi:10.14814/phy2.13453 · Cited by 35
HIF1α-dependent uncoupling of glycolysis suppresses tumor cell proliferation
Urrutia, A. A., Mesa‐Ciller, C., Guajardo-Grence, A., Alkan, H. F., Soro-Arnáiz, I., Vandekeere, A., Campos, A. M. F., Igelmann, S., Fernández-Arroyo, L., Rinaldi, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114103 · Cited by 34
N-terminal cysteine acetylation and oxidation patterns may define protein stability
Heathcote, K. C., Keeley, T. P., Myllykoski, M., Lundekvam, M., McTiernan, N., Akter, M. S., Masson, N., Ratcliffe, P. J., Arnesen, T., & Flashman, E. (2024) · Nature Communications · doi:10.1038/s41467-024-49489-2 · Cited by 35
Self-citationReduced adipocyte glutaminase activity promotes energy expenditure and metabolic health
Lecoutre, S., Maqdasy, S., Rizo‐Roca, D., Renzi, G., Vlassakev, I., Alaeddine, L. M., Higos, R., Jalkanen, J., Zhong, J., Zareifi, D., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01083-y · Cited by 33
“4c) 23 .”
Zhang, F., Shen, G., Liu, X., Wang, F., Zhao, H.-L., Yu, J., & Zhang, J. (2011) · Biochemistry · doi:10.1021/bi101585c · Cited by 35
Zhao, D., Qu, Q., Dai, H., Liu, Y., Jiang, L., Huang, X. Y., & Hao, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7890 · Cited by 41
“HIF-1 is a heterodimer, which comprises α and β subunits (10).”
Modelling pyruvate dehydrogenase under hypoxia and its role in cancer metabolism
Eyassu, F., & Angione, C. (2017) · Royal Society Open Science · doi:10.1098/rsos.170360 · Cited by 30
Pulmonary endoplasmic reticulum stress—scars, smoke, and suffocation
Dickens, J. A., Malzer, E., Chambers, J. E., & Marciniak, S. J. (2018) · FEBS Journal · doi:10.1111/febs.14381 · Cited by 30
Revisiting the role of hypoxia-inducible factors in pulmonary hypertension
Shimoda, L. A., Yun, X., & Sikka, G. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.12.003 · Cited by 31
“The COOH-terminal halves of HIF-1a and HIF-2a contain two transactivation domains and O2-dependent degradation domains [24,25].”
BackgroundYun, C. C. (2019) · Cancers · doi:10.3390/cancers11070958 · Cited by 28
“Once synthesized, HIF-1α protein is stabilized via its interaction with macrophage migration inhibitory factor (MIF), hence retarding oxygen-dependent hydroxylation and proteasomal degradation [148,151,152].”
BackgroundWagner, A., Hofmeister, O., Rolland, S. G. M., Maiser, A., Aasumets, K., Schmitt, S., Schorpp, K., Feuchtinger, A., Hadian, K., Schneider, S., et al. (2019) · Journal of Cell Science · doi:10.1242/jcs.223891 · Cited by 28
Domene, C., Jorgensen, C., & Schofield, C. J. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09236 · Cited by 32
“and HIF-α levels rise; HIF-α can then translocate to the nucleus and it can dimerize with HIF- and promote the transcription of HIF target genes.(5)”
BackgroundSelf-citationVitamin C in Pneumonia and Sepsis
Carr, A. C. (2020) · CRC Press eBooks · doi:10.1201/9780429442025-7 · Cited by 42
Metadata
- Authors
- Schofield, C. J., & Ratcliffe, P. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Ratcliffe, Peter J.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2004-05
- Volume
- 5
- Issue
- 5
- Pages
- 343-354
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1991346678
- Semantic Scholar
- 17237b87d7ea79ae6e18c24d4de83bfeffbd7c2e
- Cited by
- 2,068
- References
- 109
- Citations by year
- 2026: 62 · 2025: 55 · 2024: 92 · 2023: 90 · 2022: 121 · 2021: 95 · 2020: 106 · 2019: 80 · 2018: 95 · 2017: 91 · 2016: 106 · 2015: 99 · 2014: 120 · 2013: 83 · 2012: 76
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Medical Research Council
- Biotechnology and Biological Sciences Research Council (B18672, BBS/B/07683)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, oxygen sensing, 2-oxoglutarate-dependent dioxygenase, oxygen homeostasis, transcriptional regulation, molecular oxygen
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Hydroxylation, Ketoglutaric Acids, Oxygen, Oxygenases, Transcription Factors, Cell Hypoxia, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.